Fresenius SE & Co. KGaA (FSNUY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 7.60 |
| Open | 7.60 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 7.57 - 7.73 |
| 52-week range | 6.33 - 8.38 |
| Volume | |
| Avg. volume | 51,916 |
| Market cap | 17.415B |
| Beta (5Y monthly) | 1.08 |
| PE ratio (TTM) | 45.47 |
| EPS (TTM) | 0.17 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | 0.25 (3.21%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | N/A |
BloombergFresenius Sells Controlling Stake in Vamed Rehab Business to PAI
(Bloomberg) -- Fresenius SE has agreed to sell a controlling stake in the rehabilitation business of its Vamed unit to French private equity firm PAI Partners as the German healthcare company further trims its portfolio.Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesBiden Calls Ally Japan ‘Xenophobic’ Along With China, RussiaIn Jamie Dimo
Simply Wall St.Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
- Simply Wall St.
Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Today we're going to take a look at the well-established Fresenius SE & Co. KGaA ( ETR:FRE ). The company's stock saw...
© 2024 Yahoo. All rights reserved.